title: Induction of apoptosis in human eosinophils by anti-Fas antibody treatment in vitro.
abstract: Fas antigen (CD95) can induce apoptosis of cells such as lymphocytes and neutrophils. To determine whether Fas antigen is involved in eosinophil apoptosis, we examined its expression and function on eosinophils in vitro. Purified human eosinophils expressed low but consistently detectable levels of Fas antigen. Culture of eosinophils in up to 10 ng/mL interleukin-5 (IL-5) prolonged eosinophil survival; incorporation of 1 to 1,000 ng/mL Fas antibody led to significant reductions in IL-5-induced eosinophil viability after 48 to 72 hours of culture. Reductions in survival could not be overcome by IL-5 and also occurred in the absence of exogenous IL-5. Preactivation of eosinophils with platelet-activating factor (PAF) significantly reduced eosinophil viability without altering the survival-reducing effects of Fas antibody treatment. In contrast, RANTES did not affect eosinophil viability or Fas antibody-induced reductions in eosinophil survival. After treatment with Fas antibody, electron microscopy of eosinophils and gel electrophoresis of DNA extracted from eosinophils demonstrated changes consistent with apoptosis. These data demonstrate that Fas antigen can modify eosinophil survival by inducing apoptosis through a pathway that is, at least in part, independent of the survival-promoting effects of IL-5.
authors.affiliation: Johns Hopkins Asthma and Allergy Center, Baltimore, MD 21224-6801, USA.
authors.forename: K
authors.initials: K
authors.lastname: Matsumoto
authors.forename: R P
authors.initials: RP
authors.lastname: Schleimer
authors.forename: H
authors.initials: H
authors.lastname: Saito
authors.forename: Y
authors.initials: Y
authors.lastname: Iikura
authors.forename: B S
authors.initials: BS
authors.lastname: Bochner
mesh_terms: D000937:Antigen-Antibody Reactions; D000954:Antigens, Surface / Q000502:physiology*; D017209:Apoptosis; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D004249:DNA Damage; D004804:Eosinophils / Q000166:cytology* / Q000276:immunology; D006801:Humans; D066298:In Vitro Techniques; D015848:Interleukin-5 / Q000494:pharmacology; D008854:Microscopy, Electron; D010972:Platelet Activating Factor / Q000494:pharmacology; D019014:fas Receptor
chemical_list: D000954:Antigens, Surface; D015848:Interleukin-5; D010972:Platelet Activating Factor; D019014:fas Receptor